Results
|
161.
|
|
|
162.
|
|
|
163.
|
Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients. [electronic resource] by
- Lefèvre, G
- Sedek, G
- Jhee, S S
- Leibowitz, M T
- Huang, H-La
- Enz, A
- Maton, S
- Ereshefsky, L
- Pommier, F
- Schmidli, H
- Appel-Dingemanse, S
Producer: 20080124
In:
Clinical pharmacology and therapeutics vol. 83
Availability: No items available.
|
|
164.
|
A novel insulin secretagogue is a phosphodiesterase inhibitor. [electronic resource] by
- Leibowitz, M D
- Biswas, C
- Brady, E J
- Conti, M
- Cullinan, C A
- Hayes, N S
- Manganiello, V C
- Saperstein, R
- Wang, L H
- Zafian, P T
Producer: 19950207
In:
Diabetes vol. 44
Availability: No items available.
|
|
165.
|
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. [electronic resource] by
- Desreumaux, P
- Dubuquoy, L
- Nutten, S
- Peuchmaur, M
- Englaro, W
- Schoonjans, K
- Derijard, B
- Desvergne, B
- Wahli, W
- Chambon, P
- Leibowitz, M D
- Colombel, J F
- Auwerx, J
Producer: 20010503
In:
The Journal of experimental medicine vol. 193
Availability: No items available.
|
|
166.
|
A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus. [electronic resource] by
- Berger, J
- Patel, H V
- Woods, J
- Hayes, N S
- Parent, S A
- Clemas, J
- Leibowitz, M D
- Elbrecht, A
- Rachubinski, R A
- Capone, J P
- Moller, D E
Producer: 20000828
In:
Molecular and cellular endocrinology vol. 162
Availability: No items available.
|
|
167.
|
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. [electronic resource] by
- Sramek, J J
- Leibowitz, M T
- Weinstein, S P
- Rowe, E D
- Mendel, C M
- Levy, B
- McMahon, F G
- Mullican, W S
- Toth, P D
- Cutler, N R
Producer: 20020321
In:
Journal of human hypertension vol. 16
Availability: No items available.
|
|
168.
|
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. [electronic resource] by
- Claudel, T
- Leibowitz, M D
- Fiévet, C
- Tailleux, A
- Wagner, B
- Repa, J J
- Torpier, G
- Lobaccaro, J M
- Paterniti, J R
- Mangelsdorf, D J
- Heyman, R A
- Auwerx, J
Producer: 20010913
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 98
Availability: No items available.
|
|
169.
|
Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. [electronic resource] by
- Gomez-Mancilla, B
- Cutler, N R
- Leibowitz, M T
- Spierings, E L
- Klapper, J A
- Diamond, S
- Goldstein, J
- Smith, T
- Couch, J R
- Fleishaker, J
- Azie, N
- Blunt, D E
Producer: 20011204
In:
Cephalalgia : an international journal of headache vol. 21
Availability: No items available.
|
|
170.
|
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. [electronic resource] by
- Davies, P J
- Berry, S A
- Shipley, G L
- Eckel, R H
- Hennuyer, N
- Crombie, D L
- Ogilvie, K M
- Peinado-Onsurbe, J
- Fievet, C
- Leibowitz, M D
- Heyman, R A
- Auwerx, J
Producer: 20010329
In:
Molecular pharmacology vol. 59
Availability: No items available.
|
|
171.
|
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. [electronic resource] by
- Kompoliti, K
- Adler, C H
- Raman, R
- Pincus, J H
- Leibowitz, M T
- Ferry, J J
- Blasucci, L
- Caviness, J N
- Leurgans, S
- Chase, W M
- Yones, L C
- Tan, E
- Carvey, P
- Goetz, C G
Producer: 20020524
In:
Neurology vol. 58
Availability: No items available.
|
|
172.
|
Design and synthesis of fluorinated RXR modulators. [electronic resource] by
- Gernert, D L
- Ajamie, R
- Ardecky, R A
- Bell, M G
- Leibowitz, M D
- Mais, D A
- Mapes, C M
- Michellys, P Y
- Rungta, D
- Reifel-Miller, A
- Tyhonas, J S
- Yumibe, N
- Grese, T A
Producer: 20040503
In:
Bioorganic & medicinal chemistry letters vol. 13
Availability: No items available.
|
|
173.
|
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors. [electronic resource] by
- Kemper, C A
- Witt, M D
- Keiser, P H
- Dubé, M P
- Forthal, D N
- Leibowitz, M
- Smith, D S
- Rigby, A
- Hellmann, N S
- Lie, Y S
- Leedom, J
- Richman, D
- McCutchan, J A
- Haubrich, R
Producer: 20010705
In:
AIDS (London, England) vol. 15
Availability: No items available.
|
|
174.
|
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. [electronic resource] by
- Zhang, B
- Graziano, M P
- Doebber, T W
- Leibowitz, M D
- White-Carrington, S
- Szalkowski, D M
- Hey, P J
- Wu, M
- Cullinan, C A
- Bailey, P
- Lollmann, B
- Frederich, R
- Flier, J S
- Strader, C D
- Smith, R G
Producer: 19960618
In:
The Journal of biological chemistry vol. 271
Availability: No items available.
|
|
175.
|
Activation of PPARdelta alters lipid metabolism in db/db mice. [electronic resource] by
- Leibowitz, M D
- Fiévet, C
- Hennuyer, N
- Peinado-Onsurbe, J
- Duez, H
- Bergera, J
- Cullinan, C A
- Sparrow, C P
- Baffic, J
- Berger, G D
- Santini, C
- Marquis, R W
- Tolman, R L
- Smith, R G
- Moller, D E
- Auwerx, J
Producer: 20000707
In:
FEBS letters vol. 473
Availability: No items available.
|
|
176.
|
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects. [electronic resource] by
- Berger, J
- Leibowitz, M D
- Doebber, T W
- Elbrecht, A
- Zhang, B
- Zhou, G
- Biswas, C
- Cullinan, C A
- Hayes, N S
- Li, Y
- Tanen, M
- Ventre, J
- Wu, M S
- Berger, G D
- Mosley, R
- Marquis, R
- Santini, C
- Sahoo, S P
- Tolman, R L
- Smith, R G
- Moller, D E
Producer: 19990330
In:
The Journal of biological chemistry vol. 274
Availability: No items available.
|
|
177.
|
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes. [electronic resource] by
- Michellys, P Y
- Ardecky, R J
- Chen, J H
- Crombie, D L
- Etgen, G J
- Faul, M M
- Faulkner, A L
- Grese, T A
- Heyman, R A
- Karanewsky, D S
- Klausing, K
- Leibowitz, M D
- Liu, S
- Mais, D A
- Mapes, C M
- Marschke, K B
- Reifel-Miller, A
- Ogilvie, K M
- Rungta, D
- Thompson, A W
- Tyhonas, J S
- Boehm, M F
Producer: 20030715
In:
Journal of medicinal chemistry vol. 46
Availability: No items available.
|